The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Status:
Not yet recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
Obesity prevalence in persons with T1D has increased, which further complicates management
and risk for complications. The proposed study is relevant to public health because it helps
us understand the role of the gut microbiome in disease pathophysiology in T1D youth with
obesity as well as potential mechanisms to modify disease.